Pharma Times -- UK patients suffering from advanced breast cancer have gained a new treatment option after Japanese drugmaker Eisai launched its marine-based drug Halaven onto the market.
Pharma Times -- UK patients suffering from advanced breast cancer have gained a new treatment option after Japanese drugmaker Eisai launched its marine-based drug Halaven onto the market.
